- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 309/30 - Atomes d'oxygène, p. ex. delta-lactones
Détention brevets de la classe C07D 309/30
Brevets de cette classe: 225
Historique des publications depuis 10 ans
|
14
|
16
|
21
|
10
|
17
|
11
|
9
|
14
|
4
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| California Institute of Technology | 4037 |
9 |
| Pharma Mar, S.A. | 213 |
7 |
| Archer Daniels Midland Company | 1077 |
6 |
| Regents of the University of Minnesota | 2791 |
6 |
| Visolis, Inc. | 35 |
5 |
| Wisconsin Alumni Research Foundation | 3902 |
4 |
| JSR Corporation | 2558 |
4 |
| Northwestern University | 3546 |
4 |
| Neuron Biopharma, S.A. | 9 |
4 |
| Viotika Life Sciences Inc. | 6 |
4 |
| BASF SE | 21308 |
3 |
| Conagen Inc. | 177 |
3 |
| Cornell University | 3426 |
3 |
| National Research Council of Canada | 1548 |
3 |
| Okinawa Institute of Science and Technology School Corporation | 173 |
3 |
| P2 Science, Inc. | 112 |
3 |
| PTT Global Chemical PCL | 121 |
3 |
| Ultupharma AB | 11 |
3 |
| Akanocure Pharmaceuticals, Inc. | 4 |
3 |
| Flagship Pioneering Innovations VI, LLC. | 600 |
3 |
| Autres propriétaires | 142 |